title: [Management of benign prostate syndrome].
authors.affiliation: Urologische Klinik und Poliklinik, Campus Grosshadern, Klinikum der Universität München (LMU), Marchioninistrasse 15, D-81377 München. annika.herlemann@med.uni-muenchen.de
authors.forename: Annika
authors.initials: A
authors.lastname: Herlemann
authors.forename: Frank
authors.initials: F
authors.lastname: Strittmatter
authors.forename: Christian G
authors.initials: CG
authors.lastname: Stief
authors.forename: Christian
authors.initials: C
authors.lastname: Gratzke
mesh_terms: D058891:5-alpha Reductase Inhibitors / Q000627:therapeutic use; D058668:Adrenergic alpha-1 Receptor Antagonists / Q000627:therapeutic use; D006801:Humans; D053685:Laser Therapy / Q000295:instrumentation; D008297:Male; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D019370:Observation; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use; D008517:Phytotherapy; D011468:Prostatectomy / Q000295:instrumentation; D011470:Prostatic Hyperplasia / Q000175:diagnosis* / Q000628:therapy*; D053448:Prostatism / Q000175:diagnosis* / Q000628:therapy*; D012371:Robotics; D020728:Transurethral Resection of Prostate / Q000295:instrumentation
chemical_list: D058891:5-alpha Reductase Inhibitors; D058668:Adrenergic alpha-1 Receptor Antagonists; D018727:Muscarinic Antagonists; D058986:Phosphodiesterase 5 Inhibitors